Gene · 3669
Papers4,236
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
801 to 820 of 4,236
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comparison of blood and lymph node cells after intramuscular injection with HIV envelope immunogens. | Front Immunol | 2022 | 36275655 | PubTator, text mining | PubMed |
Comprehensive single cell analysis of pandemic influenza A virus infection in the human airways uncovers cell-type specific host transcriptional signatures relevant for disease progression and pathogenesis. | Front Immunol | 2022 | 36268025 | PubTator, text mining | PubMed |
| Lung adenocarcinoma patients with malignant pleural effusions in hot adaptive immunity status have a longer overall survival. | Front Oncol | 2022 | 36267973 | PubTator, text mining | PubMed |
| Total marrow irradiation (TMI): Addressing an unmet need in hematopoietic cell transplantation - a single institution experience review. | Front Oncol | 2022 | 36263219 | PubTator, text mining | PubMed |
| Peripheral T cell cytotoxicity predicts the efficacy of anti-PD-1 therapy for advanced non-small cell lung cancer patients. | Sci Rep | 2022 | 36261600 | PubTator, text mining | PubMed |
| MPYS Modulates Fatty Acid Metabolism and Immune Tolerance at Homeostasis Independent of Type I IFNs. | J Immunol | 2022 | 36261171 | PubTator, text mining | PubMed |
| Delineating the transcriptional landscape and clonal diversity of virus-specific CD4+ T cells during chronic viral infection. | Elife | 2022 | 36255051 | PubTator, text mining | PubMed |
| Characterization of exogenous αSN response genes and their relation to Parkinson's disease using network analyses. | Front Pharmacol | 2022 | 36249814 | PubTator, text mining | PubMed |
| B cell deficiency promotes the initiation and progression of lung cancer. | Front Oncol | 2022 | 36249034 | PubTator, text mining | PubMed |
| Knowledge mapping of targeted immunotherapy for myasthenia gravis from 1998 to 2022: A bibliometric analysis. | Front Immunol | 2022 | 36248874 | PubTator, text mining | PubMed |
| GPI: An indicator for immune infiltrates and prognosis of human breast cancer from a comprehensive analysis. | Front Endocrinol (Lausanne) | 2022 | 36246907 | PubTator, text mining | PubMed |
| Not enough by half: NFAT5 haploinsufficiency in two patients with Epstein-Barr virus susceptibility. | Front Immunol | 2022 | 36238298 | PubTator, text mining | PubMed |
| Longitudinal COVID-19 immune trajectories in patients with neurological autoimmunity on anti-CD20 therapy. | Mult Scler Relat Disord | 2022 | 36223705 | PubTator, text mining | PubMed |
| An anti-influenza combined therapy assessed by single cell RNA-sequencing. | Commun Biol | 2022 | 36216966 | PubTator, text mining | PubMed |
| A real-time GPU-accelerated parallelized image processor for large-scale multiplexed fluorescence microscopy data. | Front Immunol | 2022 | 36211386 | PubTator, text mining | PubMed |
| Evaluation of immune system in patients with transfusion-dependent beta-thalassemia in Rasoul-e-Akram Hospital in 2021: A descriptive cross-sectional study. | Health Sci Rep | 2022 | 36210881 | PubTator, text mining | PubMed |
| Decoding the colorectal cancer ecosystem emphasizes the cooperative role of cancer cells, TAMs and CAFsin tumor progression. | J Transl Med | 2022 | 36209225 | PubTator, text mining | PubMed |
| Revealing the characteristics of ZIKV infection through tissue-specific transcriptome sequencing analysis. | BMC Genomics | 2022 | 36209057 | PubTator, text mining | PubMed |
| RAD21 amplification epigenetically suppresses interferon signaling to promote immune evasion in ovarian cancer. | J Clin Invest | 2022 | 36201246 | PubTator, text mining | PubMed |
| KLHDC8A Expression in Association with Macrophage Infiltration and Oxidative Stress Predicts Unfavorable Prognosis for Glioma. | Oxid Med Cell Longev | 2022 | 36199422 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3669/papers?page=41